Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2018

Open Access 01-04-2018 | Original Article

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

Authors: Femke Jansen, Veerle M. H. Coupé, Simone E. J. Eerenstein, C. René Leemans, Irma M. Verdonck-de Leeuw

Published in: Supportive Care in Cancer | Issue 4/2018

Login to get access

Abstract

Purpose

The aim of this study is to investigate the associations between patient activation and total costs in cancer patients treated with total laryngectomy (TL).

Methods

All members of the Dutch Patients’ Association for Laryngectomees were asked to participate in this cross-sectional study. TL patients who wanted to participate were asked to complete a survey. Costs were measured using the medical consumption and productivity cost questionnaire and patient activation using the Patient Activation Measure (PAM). Sociodemographic and clinical characteristics were self-reported, and health status measured using the EQ-5D. The difference in total costs from a healthcare and societal perspective among four groups with different PAM levels were compared using (multiple) regression analyses (5000 bootstrap replications).

Results

In total, 248 TL patients participated. Patients with a higher (better) PAM (levels 2, 3, and 4) had a probability of 70, 80, and 93% that total costs from a healthcare perspective were lower than in patients with the lowest PAM level (difference €−375 to €−936). From a societal perspective, this was 73, 87, and 82% (difference €−468 to €−719). After adjustment for time since TL, education, and sex, the probability that total costs were lower in patients with a higher PAM level compared to patients with the lowest PAM level changed to 62–91% (healthcare) and 63–92% (societal). After additional adjustment for health status, the probability to be less costly changed to 35–71% (healthcare) and 31–48% (societal).

Conclusions

A better patient activation is likely to be associated with lower total costs from a healthcare and societal perspective.
Literature
1.
Gee PM, Greenwood DA, Paterniti DA, Ward D, Miller LMS (2015) The eHealth enhanced chronic care model: a theory derivation approach. J Med Internet Res 17:e86CrossRefPubMedPubMedCentral
2.
McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH (2011) Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 61:50–62CrossRefPubMedPubMedCentral
3.
Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A (2001) Improving chronic illness care: translating evidence into action. Health Aff (Millwood ) 20:64–78CrossRef
4.
Neuhauser D (2003) The coming third health care revolution: personal empowerment Q manage. Health Care 12:171–184
5.
Ventura F, Ohlen J, Koinberg I (2013) An integrative review of supportive e-health programs in cancer care. Eur J Oncol Nurs 17:498–507CrossRefPubMed
6.
Slev VN, Mistiaen P, Pasman HR, Verdonck-de Leeuw IM, van Uden-Kraan CF, Francke AL (2016) Effects of eHealth for patients and informal caregivers confronted with cancer: a meta-review. Int J Med Inform 87:54–67CrossRefPubMed
7.
Howell D, Harth T, Brown J, Bennett C, Boyko S (2017) Self-management education interventions for patients with cancer: a systematic review. Support Care Cancer 25:1323–1355CrossRefPubMed
8.
van den Berg SW, Gielissen MF, Ottevanger PB, Prins JB (2012) Rationale of the BREAst cancer e-healTH [BREATH] multicentre randomised controlled trial: an internet-based self-management intervention to foster adjustment after curative breast cancer by decreasing distress and increasing empowerment. BMC Cancer 12:394CrossRefPubMedPubMedCentral
9.
van Helmondt SJ, van der Lee ML, de Vries J (2016) Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer. BMC Cancer 16:527CrossRefPubMedPubMedCentral
10.
Jansen F, Cnossen IC, Eerenstein SEJ, Coupé VMH, Witte BI, van Uden-Kraan CF, Doornaert P, Braunius WW, de Bree R, Hardillo JAU, Honings J, Halmos GB, Leemans CR, Verdonck-de Leeuw IM (2016) Effectiveness and cost-utility of a guided self-help exercise program for patients treated with total laryngectomy: protocol of a multi-center randomized controlled trial. BMC Cancer 16:580CrossRefPubMedPubMedCentral
11.
Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, van der Velden LA, Lacko M, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM (2016) Feasibility of an eHealth application “OncoKompas” to improve personalized survivorship cancer care. Support Care Cancer 24:2163–2171CrossRefPubMed
12.
Chatterton ML, Chambers S, Occhipinti S, Girgis A, Dunn J, Carter R, Shih S, Mihalopoulos C (2016) Economic evaluation of a psychological intervention for high distress cancer patients and carers: costs and quality-adjusted life years. Psychooncology 25:857–864CrossRefPubMed
13.
Krebber AM, Jansen F, Witte BI, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout AM, Beekman AT, Leemans CR, Verdonck-de Leeuw IM (2016) Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trial. Ann Oncol 27:1754–1760CrossRefPubMed
14.
Bodenheimer T, Lorig K, Holman H, Grumbach K (2002) Patient self-management of chronic disease in primary care. JAMA 288:2469–2475CrossRefPubMed
15.
Panagioti M, Richardson G, Small N, Murray E, Rogers A, Kennedy A, Newman S, Bower P (2014) Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res 14:356CrossRefPubMedPubMedCentral
16.
Jansen F, Krebber AM, Coupe VM, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman AT, Leemans CR, Verdonck-de Leeuw IM (2017) Cost-utility of stepped care targeting psychological distress in patients with head and neck or lung cancer. J Clin Oncol 35:314–324CrossRefPubMed
17.
Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M (2012) Measuring patient activation in The Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13). BMC Public Health 12:577CrossRefPubMedPubMedCentral
18.
Greene J, Hibbard JH, Sacks R, Overton V, Parrotta CD (2015) When patient activation levels change, health outcomes and costs change, too. Health Aff (Millwood ) 34:431–437CrossRef
19.
Hendriks M, Rademakers J (2014) Relationships between patient activation, disease-specific knowledge and health outcomes among people with diabetes; a survey study. BMC Health Serv Res 14:393CrossRefPubMedPubMedCentral
20.
Remmers C, Hibbard J, Mosen DM, Wagenfield M, Hoye RE, Jones C (2009) Is patient activation associated with future health outcomes and healthcare utilization among patients with diabetes? J Ambulatory Care Manage 32:320–327CrossRefPubMed
21.
Rask KJ, Ziemer DC, Kohler SA, Hawley JN, Arinde FJ, Barnes CS (2009) Patient activation is associated with healthy behaviors and ease in managing diabetes in an indigent population. Diabetes Educator 35:622–630CrossRefPubMed
22.
Greene J, Hibbard JH (2011) Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 27:520–526CrossRefPubMedCentral
23.
Begum N, Donald M, Ozolins IZ, Dower J (2011) Hospital admissions, emergency department utilisation and patient activation for self-management among people with diabetes. Diabetes Res Clin Pract 93:260–267CrossRefPubMed
24.
Mitchell SE, Gardiner PM, Sadikova E, Martin JM, Jack BW, Hibbard JH, Paasche-Orlow MK (2013) Patient activation and 30-day post-discharge hospital utilization. J Gen Intern Med 29:349–355CrossRefPubMedPubMedCentral
25.
Kinney RL, Lemon SC, Person SD, Pagoto SL, Saczynski JS (2015) The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: a systematic review. Patient Educ Couns 98:545–552CrossRefPubMed
26.
Hibbard JH, Greene J, Overton V (2013) Patients with lower activation associated with higher costs; delivery systems should know their patients’ ‘scores’. Health Aff (Millwood) 32:216–222CrossRef
27.
Burnip E, Owen SJ, Barker S, Patterson JM (2013) Swallowing outcomes following surgical and non-surgical treatment for advanced laryngeal cancer. J Laryngol Otol 127:1116–1121CrossRefPubMed
28.
Perry A, Casey E, Cotton S (2015) Quality of life after total laryngectomy: functioning, psychological well-being and self-efficacy. Int J Lang Commun Disord 50:467–475CrossRefPubMed
29.
Singer S, Danker H, Guntinas-Lichius O, Oeken J, Pabst F, Schock J, Vogel HJ, Meister EF, Wulke C, Dietz A (2014) Quality of life before and after total laryngectomy: results of a multicenter prospective cohort study. Head Neck:359–368
30.
Szuecs M, Kuhnt T, Punke C, Witt G, Klautke G, Kramp B, Hildebrandt G (2015) Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer. J Radiat Res 56:168CrossRef
31.
Moukarbel RV, Fung K, Franklin JH, Leung A, Rastogi R, Anderson CM, Yoo JH (2010) Neck and shoulder disability following reconstruction with the pectoralis major pedicled flap. Laryngoscope 120:1129–1134PubMed
32.
Gourin CG, Dy SM, Herbert RJ, Blackford AL, Quon H, Forastiere AA, Eisele DW, Frick KD (2014) Treatment, survival, and costs of laryngeal cancer care in the elderly. Laryngoscope 124:1827–1835CrossRefPubMed
33.
Cohen SM, Kim J, Roy N, Asche C, Courey M (2012) The impact of laryngeal disorders on work-related dysfunction. Laryngoscope 122:1589–1594CrossRefPubMed
34.
Bouwmans C, Hakkaart-van Rooijen L, Koopmanschap M, Krol M, Severens H, Brouwer W (2013) Handleiding iMTA Medical Consumption Questionnaire. In: Editor (ed)^(eds) Book Handleiding iMTA Medical Consumption Questionnaire
35.
Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M, Severens H, Brouwer W (2013) Handleiding iMTA Productivity Costs Questionnaire. In: Editor (ed)^(eds) Book Handleiding iMTA Productivity Costs Questionnaire
36.
Hakkaart-van Rooijen L, Tan SS, Bouwmans CAM (2010) Handleiding voor kostenonderzoek Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. In: Editor (ed)^(eds) Book Handleiding voor kostenonderzoek Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg
37.
Hibbard JH, Stockard J, Mahoney ER, Tusler M (2004) Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39:1005–1026CrossRefPubMedPubMedCentral
38.
39.
Lamers LM, Stalmeier PFM, McDonnell J, Krabbe PFM, van Busschbach JJ (2005) Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 149:1574–1578PubMed
40.
Magnezi R, Glasser S, Shalev H, Sheiber A, Reuveni H (2014) Patient activation, depression and quality of life. Patient Educ Couns 94:432–437CrossRefPubMed
41.
Elliott R, Payne K (2004) Statistical handling of data in economic analysis Essentials of Economic Evaluation in Healthcare. Pharmaceutical Press
42.
Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14:1165–1174CrossRefPubMed
43.
Kvale EA, Huang CS, Meneses KM, Demark-Wahnefried W, Bae S, Azuero CB, Rocque GB, Bevis KS, Ritchie CS (2016) Patient-centered support in the survivorship care transition: outcomes from the patient-owned survivorship care plan intervention. Cancer 122:3232–3242CrossRefPubMed
44.
Lara-Cabrera ML, Salvesen O, Nesset MB, De las Cuevas C, Iversen VC, Grawe RW (2016) The effect of a brief educational programme added to mental health treatment to improve patient activation: a randomized controlled trial in community mental health centres. Patient Educ Couns 99:760–768CrossRefPubMed
45.
McCusker J, Lambert SD, Cole MG, Ciampi A, Strumpf E, Freeman EE, Belzile E (2016) Activation and self-efficacy in a randomized trial of a depression self-care intervention. Health Educ Behav 43:716–725CrossRefPubMed
Metadata
Title
Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?
Authors
Femke Jansen
Veerle M. H. Coupé
Simone E. J. Eerenstein
C. René Leemans
Irma M. Verdonck-de Leeuw
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3945-8

Other articles of this Issue 4/2018

Supportive Care in Cancer 4/2018 Go to the issue

Original Article

Patient-reported physical activity and the association with health-related quality of life in head and neck cancer survivors

Review Article

Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia

Original Article

Building psychosocial capacity through training of front-line health professionals to provide brief therapy: lessons learned from the PROMPT study

Original Article

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

Original Article

Serotonin transporter polymorphism, depressive symptoms, and emotional impulsivity among advanced breast cancer patients

Original Article

Patients with advanced periodontal disease before intensity-modulated radiation therapy are prone to develop bone healing problems: a 2-year prospective follow-up study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits